Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 2, 2010, Pages 730-733

  Bandgar, Babasaheb P ^a,b   Patil, Sachin A ^b   Gacche, Rajesh N ^b   Korbad, Balaji L ^b   Hote, Balwant S ^b   Kinkar, Santosh N ^b   Jalde, Shivkumar S ^b  

^a SOLAPUR UNIVERSITY   (India)

^b SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Anti inflammatory; Antioxidant activity; Nitrogen containing chalcones

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETA GLUCURONIDASE; CHALCONE DERIVATIVE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; METHYL GROUP; NITROGEN; SCAVENGER; TRYPSIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG INHIBITION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; MANNICH REACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CHALCONES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; GLUCURONIDASE; NITROGEN; TRYPSIN; TRYPSIN INHIBITORS;

EID: 72249112526     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.11.068     Document Type: Article

References (40)

1. Movat H.Z. Immunity and Hypersensitivity (1971), Harper and Row Publisher, New York
2. Herencia F., Ferrandiz M.L., Ubeda A., Guillen I., and Chan G.M. Free Radical Biol. Med. 30 (2001) 43
3. Jang D.S., Park E.J., Kang Y.H., Hawthrone M.E., Vigo J.S., Graham J.G., Fong H.S., Mehata R.G., Pezzuto J.M., and Kinghorn A.D. J. Nat. Prod. 66 (2003) 1116
4. Viana G.S.B., Bandeira M.A.M., and Matos F.J.A. Phytomedicine 10 (2003) 189
5. Vane J.R., Bakhle Y.S., and Botting R.M. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97
6. Smith W.L., DeWitt D.L., and Garavito R.M. Annu. Rev. Biochem. 69 (2000) 97
7. DuBois R.N. FASEB J. 12 (1998) 1063
8. FitzGerald G.A., and Patrona C. N. Eng. J. Med. 345 (2001) 433
9. Flower R.J. Nat. Rev. Drug Disc. 2 (2003) 179
10. Warner T.D., and Mitchell J.A. FASEB J. 18 (2004) 790
11. Marriot J.B., Wiestby M., and Dagleish A.G. Drug Discovery Today 2 (1997) 273
12. Elsohly H.N., Joshi A.S., Nimrod A.C., Walker L.A., and Clark A.M. Planta Med. 67 (2001) 87
13. Lopez S.N., Castelli M.V., Zacchino S.A., and Enriz R.D. Bioorg. Med. Chem. 9 (2001) 1999
14. Kayser O., and Kiderlen A.F. Phytother. Res. 15 (1959) 148
15. Dominguez J.N., Charris J.E., and Lobo G. Eur. J. Med. Chem. 36 (2001) 555
16. Ram V.J., Saxena A.S., Srivastava S., and Chandra S. Bioorg. Med. Chem. 10 (2001) 2159
17. Xia Y., Yang Z.Y., Xia P., Bastow K.I., Nakanishi Y., and Lee K.-H. Bioorg. Med. Chem. Lett. 10 (2000) 699
18. Bois F., Beney C., Boumendijel A., Mariotte A.M., Conseil G., and DiPietro A. J. Med. Chem. 41 (1998) 4161
19. Hiseh H.-K., Tsao L.-T., and Wang J.-P. J. Pharm. Pharmacol. 52 (2000) 163
20. Hsieh H.-K., Lee T.-H., Wang J.-P., Wang J.-J., and Lin C.-N. Pharm. Res. 15 (1998) 39
21. Herencia F., Ferraindiz M.L., Ubeda A., Dominguez J.N., Charris J.E., Lobo G.M., and Alcaraz M.J. Bioorg. Med. Chem. Lett. 8 (1998) 1169
22. Ducki S., Forrest R., Hadfield J.A., Kendall A., Lawrence N.J., McGrown A.T., and Rennison D. Bioorg. Med. Chem. Lett. 8 (1998) 1051
23. Linn L.-M., Zhou Y., Flavin M.T., Zhou L.-M., Nie W., and Chen F.-C. Bioorg. Med. Chem. 10 (2002) 2795
24. Furman C., Lebeau J., Fruchart J.-C., Bernier J.-L., Duiez P., Cotelle N., and Teissier E. J. Biochem. Mol. Toxicol. 15 (2001) 270
25. Satyanarayana M., Tiwari P., Tripathi B.K., Srivastava A.K., and Pratab R. Bioorg. Med. Chem. 12 (2004) 883
26. Ahluwalia V.K. Intermediates for Organic Synthesis (2005), I. K. International Publisher, New Delhi p 140
27. Cechinel V.F., Vaz Z.R., Zunino L., Calixto J.B., and Yunes R.A. Eur. J. Med. Chem. 31 (1996) 833
28. Wilds A.L., Nowak R.M., and McCaleb K.E. Org. Synth. 4 (1963) 281
29. Liu T., Xu Z.M., and Hu Y.Z. Acta Crystallogr., Sect. E (2005) 3389
30. Liu T., Xu Z.M., He Q., Chen Y., Yang B., and Hu Y.Z. Bioorg. Med. Chem. Lett. 17 (2007) 278
31. +.
32. -6 M) was used as a reference drug (89.24%).β-Glucuronidase inhibition assay: The effect of the plant extracts on activity of β-glucuronidase was studied using a method described by Demetrios (1998). One millimolar concentration of test sample (0.1 mL) in 0.1 M acetate buffer pH 7.4 for 5 min at 37 °C were preincubated with 0.8 mL of 2.5 mM p-nitrophenyl-β-d-glucopyranosiduronic acid and 0.1 mL of β-glucuronidase was added. The mixture was incubated for 30 min. Reaction was terminated by addition of 2 mL of 0.5 N NaOH. The reaction mixtures were observed spectrophotometrically at 410 nm. Salicylic acid (1 mM) was used as a reference compound (23.30%).COX-2 inhibition micro-titer assay: The reaction mixture of 100% initial activity wells contained 160 μL of assay buffer, 150 μL of heme and 10 μL of COX-2 enzyme solution. While the reaction mixture of inhibitor wells was comprised of 150 μL of assay buffer, 10 μL of heme, and 10 μL of enzyme COX-2, 10 μL of the test samples (1 mM). The plates were carefully shaken for 5 s and were incubated for 5 min at 25 °C. After 5 min incubation 20 μL of the colorimetric substrate solution was added to all the wells, followed by the addition of 20 μL of arachidonic acid to all the wells. The plates were shaken gently for few seconds and again incubated for 5 min at 25 °C. The absorbance of all the wells was read at 590 nm using Thermo make Automatic Ex-Microplate Reader (M 51118170). The COX-2 inhibition activity (%) was calculated using following formulaCOX- 2 inhibition activity (%) = frac(T, C) × 100where T = absorbance of the inhibitor well at 590 nm, C = absorbance of the 100% initial activity without inhibitor well at 590 nm.
33. Paula B., Camila Alves B.F., Paulo C.L., Rosendo A.Y., Valdir C.F., Eduardo C.T.-S., and Bartira R.-B. Bioorg. Med. Chem. 14 (2006) 1538
34. Bartolome B., Nunez V., Monagas M., and Gomez-Cordoves C. Eur. Food Res. Technol. 218 (2004) 173
35. Wright J.S. Chem Br. 39 (2003) 25
36. Tandon M., Tandon P., Barthwal J.P., Bhalla T.N., and Bhargava K.P. Drug Res. 32 (1982) 1233
37. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Biol. Chem. 193 (1951) 265
38. Bilfinger T.V., and George B.S. Curr. Pharm. Design 8 (2002) 125
39. Demetrios N.N., Konstantina C.F., Konstantinos E.L., and Dimitra H.L. Eur. J. Med. Chem. 33 (1998) 715
40. Anna L.B., and Lawrence J.M. J. Med. Chem. 50 (2007) 1425